Fingerprint
Dive into the research topics of 'Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer
Shoji Nakamori, Wakio Endo, Hiroki Ozato, Takashi Shibata, Yutaka Takeda, Ken Tohno, Yasunori Hasuike, Seizo Masutani, Takashi Morimoto, Yuichirou Doki, Masaki Mori, Morito Monden
Research output: Contribution to journal › Article › peer-review
1
Citation
(Scopus)